Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wittes

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Statistics in Medicine|September 27, 2002
On changing a long-term clinical trial midstreamJanet Wittes
Statistics in Medicine|September 4, 2012
Jerome Cornfield's contributions to early large randomized clinical trials and some reminiscences from the years of the slippery doorknobsJanet Wittes
Clinical Trials (London, England)|August 11, 2012
Stopping a trial early - and then what?Janet Wittes
Journal of the National Cancer Institute|January 10, 2008
Times to event: why are they hard to visualize?Janet Wittes
The New England Journal of Medicine|November 15, 2013
Pazopanib versus sunitinib in renal cancerJanet Wittes
The Journal of Infectious Diseases|May 15, 2014
Assessing correlates of protection in vaccine trialsJanet Wittes
Clinical Trials (London, England)|April 16, 2021
Commentary on Chirkova et al.: Some comments on "socialist pharmapolitics"Janet Wittes
The American Journal of Bioethics : AJOB|March 15, 2011
Discussion of paper by Korn and FreidlinJanet Wittes
Statistics in Medicine|October 21, 2009
Commentary on 'Measurement in clinical trials: a neglected issue for statisticians?'Janet Wittes
Biostatistics (Oxford, England)|June 22, 2017
Discussion: Is FDA in need of a major change in the way it regulates?Janet Wittes
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Statistics in Medicine|September 27, 2002
On changing a long-term clinical trial midstreamJanet Wittes
Statistics in Medicine|September 4, 2012
Jerome Cornfield's contributions to early large randomized clinical trials and some reminiscences from the years of the slippery doorknobsJanet Wittes
Clinical Trials (London, England)|August 11, 2012
Stopping a trial early - and then what?Janet Wittes
Journal of the National Cancer Institute|January 10, 2008
Times to event: why are they hard to visualize?Janet Wittes
The New England Journal of Medicine|November 15, 2013
Pazopanib versus sunitinib in renal cancerJanet Wittes
The Journal of Infectious Diseases|May 15, 2014
Assessing correlates of protection in vaccine trialsJanet Wittes
Clinical Trials (London, England)|April 16, 2021
Commentary on Chirkova et al.: Some comments on "socialist pharmapolitics"Janet Wittes
The American Journal of Bioethics : AJOB|March 15, 2011
Discussion of paper by Korn and FreidlinJanet Wittes
Statistics in Medicine|October 21, 2009
Commentary on 'Measurement in clinical trials: a neglected issue for statisticians?'Janet Wittes
Biostatistics (Oxford, England)|June 22, 2017
Discussion: Is FDA in need of a major change in the way it regulates?Janet Wittes
Pageof 13